354 related articles for article (PubMed ID: 14598413)
21. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
[TBL] [Abstract][Full Text] [Related]
22. British women's choice between sentinel node biopsy and axillary node clearance for breast cancer.
Asaad M; Tamer M; Mokbel K
Curr Med Res Opin; 2003; 19(6):570-4. PubMed ID: 14594531
[TBL] [Abstract][Full Text] [Related]
23. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
Bulte CS; van der Heiden-van der Loo M; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
[TBL] [Abstract][Full Text] [Related]
24. Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer: 2-site injection is more accurate than 1-site injection.
Anan K; Mitsuyama S; Kuga H; Saimura M; Tanabe Y; Suehara N; Matsunaga H; Nishihara K; Abe Y; Iwashita T; Ihara T; Tamae K; Ono M; Toyoshima S
Surgery; 2006 May; 139(5):624-9. PubMed ID: 16701094
[TBL] [Abstract][Full Text] [Related]
25. Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study.
Coutant C; Rouzier R; Fondrinier E; Marchal F; Guillemin F; Seince N; Rodrigues A; Darai E; Uzan S; Barranger E
Breast Cancer Res Treat; 2009 Feb; 113(3):537-43. PubMed ID: 18340527
[TBL] [Abstract][Full Text] [Related]
26. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
[TBL] [Abstract][Full Text] [Related]
27. Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry. Part II. Results.
Salem AA; Douglas-Jones AG; Sweetland HM; Mansel RE
Eur J Surg Oncol; 2006 Jun; 32(5):484-7. PubMed ID: 16569493
[TBL] [Abstract][Full Text] [Related]
28. Breast sentinel lymph node dissection before preoperative chemotherapy.
Grube BJ; Christy CJ; Black D; Martel M; Harris L; Weidhaas J; Digiovanna MP; Chung G; Abu-Khalaf MM; Miller KD; Higgins SA; Philpotts L; Tavassoli FA; Lannin DR
Arch Surg; 2008 Jul; 143(7):692-9; discussion 699-700. PubMed ID: 18645113
[TBL] [Abstract][Full Text] [Related]
29. Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients.
Lee S; Kim EY; Kang SH; Kim SW; Kim SK; Kang KW; Kwon Y; Shin KH; Kang HS; Ro J; Lee ES
Breast Cancer Res Treat; 2007 May; 102(3):283-8. PubMed ID: 17063280
[TBL] [Abstract][Full Text] [Related]
30. Sentinel node biopsy with intraoperative diagnosis in patients undergoing skin-sparing mastectomy and immediate breast reconstruction.
Meretoja TJ; Jahkola TA; Toivonen TS; Krogerus LA; Heikkilä PS; von Smitten KA; Leidenius MH
Eur J Surg Oncol; 2007 Dec; 33(10):1146-9. PubMed ID: 17462851
[TBL] [Abstract][Full Text] [Related]
31. Sentinel nodes in breast cancer: relevance of axillary level II nodes and optimal number of nodes that need to be removed.
Boileau JF; Easson A; Escallon JM; Leong WL; Reedijk M; Youngson BJ; McCready DR
Ann Surg Oncol; 2008 Jun; 15(6):1710-6. PubMed ID: 18324442
[TBL] [Abstract][Full Text] [Related]
32. [Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer].
Meijnen P; Peterse JL; Nieweg OE; Rutgers EJ
Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2428-32. PubMed ID: 15626306
[TBL] [Abstract][Full Text] [Related]
33. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer.
Ahlgren J; Holmberg L; Bergh J; Liljegren G
Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042
[TBL] [Abstract][Full Text] [Related]
34. Multiple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancer.
Motomura K; Komoike Y; Inaji H; Hasegawa Y; Kasugai T; Noguchi S; Koyama H
Br J Surg; 2002 Aug; 89(8):1032-4. PubMed ID: 12153631
[TBL] [Abstract][Full Text] [Related]
35. Detection of micrometastases in lymph nodes from patients with breast cancer.
Branagan G; Hughes D; Jeffrey M; Crane-Robinson C; Perry PM
Br J Surg; 2002 Jan; 89(1):86-9. PubMed ID: 11851670
[TBL] [Abstract][Full Text] [Related]
36. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study.
Classe JM; Loussouarn D; Campion L; Fiche M; Curtet C; Dravet F; Pioud R; Rousseau C; Resche I; Sagan C
Cancer; 2004 Mar; 100(5):935-41. PubMed ID: 14983488
[TBL] [Abstract][Full Text] [Related]
37. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important.
Jones JL; Zabicki K; Christian RL; Gadd MA; Hughes KS; Lesnikoski BA; Rhei E; Specht MC; Dominguez FJ; Smith BL
Am J Surg; 2005 Oct; 190(4):517-20. PubMed ID: 16164912
[TBL] [Abstract][Full Text] [Related]
38. Preoperative lymphatic mapping does not predict the number of axillary sentinel lymph nodes identified during surgery in breast cancer patients.
Carmon M; Hain D; Shapira J; Golomb E
Breast J; 2006; 12(5):424-7. PubMed ID: 16958959
[TBL] [Abstract][Full Text] [Related]
39. Implementation of sentinel node biopsy in breast cancer patients in the Netherlands.
Ho VK; van der Heiden-van der Loo M; Rutgers EJ; van Diest PJ; Hobbelink MG; Tjan-Heijnen VC; Dirx MJ; Reedijk AM; van Dijck JA; van de Poll-Franse LV; Schaapveld M; Peeters PH
Eur J Cancer; 2008 Mar; 44(5):683-91. PubMed ID: 18314328
[TBL] [Abstract][Full Text] [Related]
40. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
